Publication:
Evaluation of six cases with alcapa syndrome: A rare but treatable cause of dilated cardiomyopathy

dc.contributor.authorÖzcan, Nur
dc.contributor.authorKızılkaya, Metehan
dc.contributor.authorAkça, Tuğberk
dc.contributor.buuauthorBostan, Özlem Mehtap
dc.contributor.buuauthorBOSTAN, ÖZLEM MEHTAP
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.
dc.date.accessioned2024-07-04T11:11:05Z
dc.date.available2024-07-04T11:11:05Z
dc.date.issued2020-12-01
dc.description.abstractINTRODUCTION: Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital cardiac anomaly that can be cured with surgical treatment. It accounts for 0.25 to 0.5% of all congenital heart diseases. ALCAPA is generally asymptomatic in the neonatal period. Dilated cardiomyopathy (DCM) and mitral valve insufficiency (MVI) are detected in patients with symptoms of heart failure. ALCAPA, which is a rare cause of DCM, early surgical treatment provides quite good prognosis in the first year of life. However, mortality is high in patients who do not receive surgical treatment.MATERIALS and METHODS: Six patients diagnosed with DCM at our clinic between January, 2005 and December, 2017 and detected with ALCAPA syndrome in their etiological assessment we re-evaluated retrospectivelyRESULTS: Of the 6 patients, 5 were female and 1 was male. The average age of diagnosis was 4,75 months. All patients had the signs and symptoms of heart failure at admission. All cases had the signs of ischemia in the chest leads, D1 and aVL in the electrocardiograms (ECGs). In allcases, echocardiography (ECHO) showed mitral insufficiency and the dilation of the left ventricle and the mean ejection fraction was 29,3% (18-39%), and the mean shortening fraction was 12,6% (8-19%) in the ECHOs. Diagnostic catheter angiography was performed for all patients and the diagnosis of ALCAPA was confirmed. All patients under went correction surgery with there implantation method. Four of the patients completely recovered after surgery. One patient died 5 days after the surgery. One patient is being followed up with medical treatment since there was no improvement in her cardiac functions after surgery.CONCLUSIONS: The ALCAPA syndrome should definitely be considered in the etiology of cases diagnosed with dilated cardiomyopathy and it should be kept in mind that ALCAPA is completely treatable disease with early diagnosis and treatment.
dc.identifier.endpage299
dc.identifier.issn1304-9054
dc.identifier.issue3
dc.identifier.startpage290
dc.identifier.urihttps://hdl.handle.net/11452/42902
dc.identifier.volume18
dc.identifier.wos000610184400002
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherBursa Uludag Univ
dc.relation.journalGuncel Pediatri-journal Of Current Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectLeft coronary-artery
dc.subjectPulmonary-artery
dc.subjectAnomalous origin
dc.subjectInfants
dc.subjectAnomalous origin of the left coronary artery from the pulmonary artery
dc.subjectAlcapa syndrome
dc.subjectDilated cardiomyopathy
dc.subjectCardiac failure
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectPediatrics
dc.titleEvaluation of six cases with alcapa syndrome: A rare but treatable cause of dilated cardiomyopathy
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication11a8d258-960b-43e2-afd8-14f539da4b93
relation.isAuthorOfPublication.latestForDiscovery11a8d258-960b-43e2-afd8-14f539da4b93

Files

Collections